Radioimmunoassay (RIA) is an in vitro assay introduced in 1959 to measure insulin levels in human plasma. It uses the principles of competitive binding and radioactivity detection. In RIA, the target antigen is radioactively labeled and allowed to compete with unlabeled antigen in a sample for binding to specific antibodies. The amount of radioactivity bound to antibodies can then be used to determine the quantity of antigen in the original sample. RIA provides a sensitive, precise, and convenient method for measuring trace amounts of various biomolecules and requires only small sample volumes. However, it also requires specialized equipment and handling of radioactive materials.